[DOI] [PubMed] [Google Scholar] 292.Chan TM, Ho SK, Tang CS, Tse KC, Lam MF, Lai KN, et al
According to the agreement, Hansoh Pharmaceutical will grant Merck exclusive global rights to develop, manufacture, and commercialize HS-10535
Just to round out that portion of the workout picture
Pausing peptide use on weekends and cyclically through therapy mimics the rhythm seen in many natural bodily systems
Furthermore, H&E staining showed that compared to the aorta of normal aging mice, the aorta of mice treated with FOXO4-DRI was thinner, and the PWV value was lower in the ultrasound detection results, which means that the mice treated with FOXO4-DRI had better vascular elasticity and better vascular function than normal aging mice (Figures 1D,E)
A key factoror lack thereofin this is the pharmaceutical companies, which are not exactly jumping on board to fund these very expensive studies